Renaissance Technologies - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$944
-15.3%
328,900
+49.0%
0.00%0.0%
Q2 2023$1,115
+171.3%
220,700
+1.5%
0.00%
+100.0%
Q1 2023$411
+3.5%
217,500
-1.4%
0.00%0.0%
Q4 2022$397
-99.9%
220,613
+1.3%
0.00%0.0%
Q3 2022$368,000
-45.0%
217,700
-20.0%
0.00%0.0%
Q2 2022$669,000
-8.7%
272,002
+2.8%
0.00%0.0%
Q1 2022$733,000
-64.3%
264,491
-31.4%
0.00%
-66.7%
Q4 2021$2,054,000
+355.4%
385,400
+1972.0%
0.00%
+200.0%
Q1 2021$451,000
-59.7%
18,600
-29.8%
0.00%0.0%
Q2 2020$1,118,00026,5070.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders